J.G.S. Veit, Y. Poumay, D. Mendes, J. Kreitinger, L. Walker, A. Paquet, . . . P. Diaz. (2021). Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders. Wiley.
Chicago Style (17th ed.) CitationJ.G.S. Veit, et al. Preclinical Assessment of Dual CYP26[A1/B1] Inhibitor, DX308, as an Improved Treatment for Keratinization Disorders. Wiley, 2021.
MLA (9th ed.) CitationJ.G.S. Veit, et al. Preclinical Assessment of Dual CYP26[A1/B1] Inhibitor, DX308, as an Improved Treatment for Keratinization Disorders. Wiley, 2021.
Warning: These citations may not always be 100% accurate.